Selected research
Industry Research
Pathogen mNGS Detection Industry Research Report 2026
Market perspective
The global Pathogen mNGS Detection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pathogen mNGS Detection market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pathogen mNGS Detection market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pathogen mNGS Detection market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pathogen mNGS Detection include BGI Genomics, Guangzhou Kingmed Diagnostics Group, Guangzhou Weiyuan Gene Technology, Capitalbio, Beijing Golden Key Gene Technology, IngeniGen, Difei Medical Technology, WillingMed Technology and Hangzhou Matridx Biotechnology and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pathogen mNGS Detection market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pathogen mNGS Detection.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pathogen mNGS Detection Market by Company
BGI Genomics
Guangzhou Kingmed Diagnostics Group
Guangzhou Weiyuan Gene Technology
Capitalbio
Beijing Golden Key Gene Technology
IngeniGen
Difei Medical Technology
WillingMed Technology
Hangzhou Matridx Biotechnology
Yuguo Biotechnology(Beijing)
Pathogen mNGS Detection Segment by Type
Technology Platform
Testing Service
Pathogen mNGS Detection Segment by Application
Hospital
Testing Facility
Other
Pathogen mNGS Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathogen mNGS Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pathogen mNGS Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathogen mNGS Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pathogen mNGS Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Technology Platform
- Testing Service
Applications
- Hospital
- Testing Facility
- Other
Companies covered
- BGI Genomics
- Guangzhou Kingmed Diagnostics Group
- Guangzhou Weiyuan Gene Technology
- Capitalbio
- Beijing Golden Key Gene Technology
- IngeniGen
- Difei Medical Technology
- WillingMed Technology
- Hangzhou Matridx Biotechnology
- Yuguo Biotechnology(Beijing)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pathogen mNGS Detection by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Technology Platform
- 2.2.3 Testing Service
- 2.3 Pathogen mNGS Detection by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Testing Facility
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Pathogen mNGS Detection Breakdown Data by Type
- 3.1 Global Pathogen mNGS Detection Historic Market Size by Type (2021-2026)
- 3.2 Global Pathogen mNGS Detection Forecasted Market Size by Type (2027-2032)
4 Pathogen mNGS Detection Breakdown Data by Application
- 4.1 Global Pathogen mNGS Detection Historic Market Size by Application (2021-2026)
- 4.2 Global Pathogen mNGS Detection Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pathogen mNGS Detection Market Perspective (2021-2032)
- 5.2 Global Pathogen mNGS Detection Growth Trends by Region
- 5.2.1 Global Pathogen mNGS Detection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pathogen mNGS Detection Historic Market Size by Region (2021-2026)
- 5.2.3 Pathogen mNGS Detection Forecasted Market Size by Region (2027-2032)
- 5.3 Pathogen mNGS Detection Market Dynamics
- 5.3.1 Pathogen mNGS Detection Industry Trends
- 5.3.2 Pathogen mNGS Detection Market Drivers
- 5.3.3 Pathogen mNGS Detection Market Challenges
- 5.3.4 Pathogen mNGS Detection Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pathogen mNGS Detection Players by Revenue
- 6.1.1 Global Top Pathogen mNGS Detection Players by Revenue (2021-2026)
- 6.1.2 Global Pathogen mNGS Detection Revenue Market Share by Players (2021-2026)
- 6.2 Global Pathogen mNGS Detection Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pathogen mNGS Detection Head Office and Area Served
- 6.4 Global Pathogen mNGS Detection Players, Product Type & Application
- 6.5 Global Pathogen mNGS Detection Manufacturers Established Date
- 6.6 Global Pathogen mNGS Detection Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pathogen mNGS Detection Market Size (2021-2032)
- 7.2 North America Pathogen mNGS Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pathogen mNGS Detection Market Size by Country (2021-2026)
- 7.4 North America Pathogen mNGS Detection Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pathogen mNGS Detection Market Size (2021-2032)
- 8.2 Europe Pathogen mNGS Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pathogen mNGS Detection Market Size by Country (2021-2026)
- 8.4 Europe Pathogen mNGS Detection Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pathogen mNGS Detection Market Size (2021-2032)
- 9.2 Asia-Pacific Pathogen mNGS Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pathogen mNGS Detection Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pathogen mNGS Detection Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pathogen mNGS Detection Market Size (2021-2032)
- 10.2 South America Pathogen mNGS Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pathogen mNGS Detection Market Size by Country (2021-2026)
- 10.4 South America Pathogen mNGS Detection Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pathogen mNGS Detection Market Size (2021-2032)
- 11.2 Middle East & Africa Pathogen mNGS Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pathogen mNGS Detection Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pathogen mNGS Detection Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BGI Genomics
- 12.1.1 BGI Genomics Company Information
- 12.1.2 BGI Genomics Business Overview
- 12.1.3 BGI Genomics Revenue in Pathogen mNGS Detection Business (2021-2026)
- 12.1.4 BGI Genomics Pathogen mNGS Detection Product Portfolio
- 12.1.5 BGI Genomics Recent Developments
- 12.2 Guangzhou Kingmed Diagnostics Group
- 12.2.1 Guangzhou Kingmed Diagnostics Group Company Information
- 12.2.2 Guangzhou Kingmed Diagnostics Group Business Overview
- 12.2.3 Guangzhou Kingmed Diagnostics Group Revenue in Pathogen mNGS Detection Business (2021-2026)
- 12.2.4 Guangzhou Kingmed Diagnostics Group Pathogen mNGS Detection Product Portfolio
- 12.2.5 Guangzhou Kingmed Diagnostics Group Recent Developments
- 12.3 Guangzhou Weiyuan Gene Technology
- 12.3.1 Guangzhou Weiyuan Gene Technology Company Information
- 12.3.2 Guangzhou Weiyuan Gene Technology Business Overview
- 12.3.3 Guangzhou Weiyuan Gene Technology Revenue in Pathogen mNGS Detection Business (2021-2026)
- 12.3.4 Guangzhou Weiyuan Gene Technology Pathogen mNGS Detection Product Portfolio
- 12.3.5 Guangzhou Weiyuan Gene Technology Recent Developments
- 12.4 Capitalbio
- 12.4.1 Capitalbio Company Information
- 12.4.2 Capitalbio Business Overview
- 12.4.3 Capitalbio Revenue in Pathogen mNGS Detection Business (2021-2026)
- 12.4.4 Capitalbio Pathogen mNGS Detection Product Portfolio
- 12.4.5 Capitalbio Recent Developments
- 12.5 Beijing Golden Key Gene Technology
- 12.5.1 Beijing Golden Key Gene Technology Company Information
- 12.5.2 Beijing Golden Key Gene Technology Business Overview
- 12.5.3 Beijing Golden Key Gene Technology Revenue in Pathogen mNGS Detection Business (2021-2026)
- 12.5.4 Beijing Golden Key Gene Technology Pathogen mNGS Detection Product Portfolio
- 12.5.5 Beijing Golden Key Gene Technology Recent Developments
- 12.6 IngeniGen
- 12.6.1 IngeniGen Company Information
- 12.6.2 IngeniGen Business Overview
- 12.6.3 IngeniGen Revenue in Pathogen mNGS Detection Business (2021-2026)
- 12.6.4 IngeniGen Pathogen mNGS Detection Product Portfolio
- 12.6.5 IngeniGen Recent Developments
- 12.7 Difei Medical Technology
- 12.7.1 Difei Medical Technology Company Information
- 12.7.2 Difei Medical Technology Business Overview
- 12.7.3 Difei Medical Technology Revenue in Pathogen mNGS Detection Business (2021-2026)
- 12.7.4 Difei Medical Technology Pathogen mNGS Detection Product Portfolio
- 12.7.5 Difei Medical Technology Recent Developments
- 12.8 WillingMed Technology
- 12.8.1 WillingMed Technology Company Information
- 12.8.2 WillingMed Technology Business Overview
- 12.8.3 WillingMed Technology Revenue in Pathogen mNGS Detection Business (2021-2026)
- 12.8.4 WillingMed Technology Pathogen mNGS Detection Product Portfolio
- 12.8.5 WillingMed Technology Recent Developments
- 12.9 Hangzhou Matridx Biotechnology
- 12.9.1 Hangzhou Matridx Biotechnology Company Information
- 12.9.2 Hangzhou Matridx Biotechnology Business Overview
- 12.9.3 Hangzhou Matridx Biotechnology Revenue in Pathogen mNGS Detection Business (2021-2026)
- 12.9.4 Hangzhou Matridx Biotechnology Pathogen mNGS Detection Product Portfolio
- 12.9.5 Hangzhou Matridx Biotechnology Recent Developments
- 12.10 Yuguo Biotechnology(Beijing)
- 12.10.1 Yuguo Biotechnology(Beijing) Company Information
- 12.10.2 Yuguo Biotechnology(Beijing) Business Overview
- 12.10.3 Yuguo Biotechnology(Beijing) Revenue in Pathogen mNGS Detection Business (2021-2026)
- 12.10.4 Yuguo Biotechnology(Beijing) Pathogen mNGS Detection Product Portfolio
- 12.10.5 Yuguo Biotechnology(Beijing) Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst